Logo

NCI Awards GeneGo $1M Phase II SBIR Grant to Discover Breast Cancer Biomarkers

Oct 03, 2006
NEW YORK (GenomeWeb News) – The National Cancer Institute has awarded GeneGo a phase II SBIR grant worth $1 million over two years related to help it discover breast cancer biomarkers, GeneGo said today.
 
The research program includes a large-scale gene-expression and genotyping study to be conducted at Mayo Clinic. GeneGo will use its MetaCore data-mining program for data analysis.
 
GeneGo said that in phase I of the grant it performed a network analysis of previously published microarray expression data.

Filed under

Informatics
Breaking News
The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.